Marc S. Raab

3 weeks ago | nature.com | Marc S. Raab |Yael Cohen |Fredrik Schjesvold |Andrew Spencer |Martin Wermke |Anita Souza | +6 more

Correction to: Leukemia https://doi.org/10.1038/s41375-023-01883-3, published online 06 April 2023In this article the wrong figure appeared as Fig. 3a; the figure should have appeared as shown below. The original article has been corrected. About this articleRaab, M.S., Cohen, Y.C., Schjesvold, F. et al. Correction: Preclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibody. Leukemia (2025).

Dec 7, 2023 | nature.com | Elias K. Mai |Hans Salwender |Marc S. Raab |Katia Mancuso |Meral Beksac |Ullrich Graeven | +6 more

AbstractEarly morbidity and mortality affect patient outcomes in multiple myeloma. Thus, we dissected the incidence and causes of morbidity/mortality during induction therapy (IT) for newly diagnosed multiple myeloma (NDMM), and developed/validated a predictive risk score. We evaluated 3700 transplant-eligible NDMM patients treated in 2005–2020 with novel agent-based triplet/quadruplet IT. Primary endpoints were severe infections, death, or a combination of both.